Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis
Clément Samoreau(Centre Hospitalier Universitaire d'Angers), Benoît Brilland(Centre National de la Recherche Scientifique), Jérémie Riou(Centre National de la Recherche Scientifique), Samuel Wacrenier(Centre Hospitalier du Mans), Jean‐Philippe Coindre(National Cancer Registry), Giorgina Barbara Piccoli(Centre Hospitalier du Mans), Fanny Guibert(National Cancer Registry), Anne Croué(Centre Hospitalier Universitaire d'Angers), Odile Blanchet(Inserm), Alice Desouche(Centre Hospitalier Universitaire d'Angers), Lise-Marie Pouteau(National Cancer Registry), Emeline Vinatier(Centre National de la Recherche Scientifique), Philippe Gatault(Centre Hospitalier Universitaire de Tours), Céline Beauvillain(National Cancer Registry), Frank Bridoux(Université de Poitiers), Jean‐François Augusto(Centre National de la Recherche Scientifique), Pierre Jourdain(Centre Hospitalier Universitaire d'Angers), Nicolás Henry(Centre National de la Recherche Scientifique), Jean‐François Subra(Centre National de la Recherche Scientifique), Cécile Martin(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Assia Djema(Centre Hospitalier de Lens), Marie‐Christine Copin(Université d'Angers)
Cited by 11
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
|Nature Reviews Nephrology|2018|544
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
|Blood|2012|543
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520